In the News: Investors Turn to Invest in China's Secondary PE Market; Mad Dash for Chinese AI Pharma IPO; and China Issues New Carbon Emissions Measures

June 11, 2024 | BY

Krista Lee

International investors find Chinese secondary PE market an alternative amid U.S.-China tensions; QuantumPharm is the first IPO under Hong Kong's new measure for pre-revenue specialist technology firms; and China releases new carbon measuring standards foreseeing new EU carbon tariffs.

Credit: Funtap/Adobe Stock

|

Secondary PE Market an Easier Way to Invest in China

Amid U.S.-China tensions and a market slump that has led to declining valuations, international investors are interested in gaining exposure to China through secondary private equity (PE) investments, according to the South China Morning Post (SCMP).

This premium content is reserved for
China Law & Practice Subscribers.

  • A database of over 3,000 essential documents including key PRC legislation translated into English
  • A choice of newsletters to alert you to changes affecting your business including sector specific updates
  • Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment
For enterprise-wide or corporate enquiries, please contact our experienced Sales Professionals at +44 (0)203 868 7546 or [email protected]